- It was a modestly risk-on session for equity markets yesterday with Europe, the tech heavy Nasdaq and the S&P500 all ending the day marginally in the green, as investors positioned themselves ahead of a busy few days of central bank meetings and economic data releases.
- This morning, AstraZeneca announced that it has entered into an agreement to acquire Icosavax in a deal that could be worth up to $1.1bn.
- Treasury yields were mixed yesterday, with investor optimism for the trajectory of interest rates expected to be tested later in the week.
Overview
Investment Solutions
Pension Solutions
SDIO
Application Forms – Intermediaries
Creating impact for your clients, their financial goals, and their future
Overview
Focused on your organisation, funding its growth, and unlocking its full potential
Debt Capital Markets
Probate Services
Dedicated to institutional wealth, stakeholder value, and a sustainable future
Overview
Investment Services
Stewardship
Supportive of you, your custodial vision, and your philanthropic goals
X